Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Brand

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 30, 2017
Fabry disease under enzyme replacement therapy-new insights in efficacy of different dosagesJohannes Krämer, Malte Lenders, Sima Canaan-Kühl, et al.
Journal of Hypertension|January 15, 2008
SAH gene variants revisited in the European Project On Genes in HypertensionValérie Tikhonoff, Jan A Staessen, Tatiana Kuznetsova, et al.
Circulation. Cardiovascular Genetics|September 12, 2014
Identification of genetic markers for treatment success in heart failure patients: insight from cardiac resynchronization therapyBoris Schmitz, Renata De Maria, Dimitris Gatsios, et al.
Circulation|October 20, 2004
Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretionTatiana Kuznetsova, Jan A Staessen, Lutgarde Thijs, et al.
Journal of the American Society of Nephrology : JASN|February 22, 2014
Patients with Fabry disease after enzyme replacement therapy dose reduction versus treatment switchFrank Weidemann, Johannes Krämer, Thomas Duning, et al.
Orphanet Journal of Rare Diseases|July 1, 2016
Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry diseaseMalte Lenders, Julia B Hennermann, Christine Kurschat, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 20, 2007
Polymorphisms in 33 inflammatory genes and risk of myocardial infarction--a system genetics approachSandrine Barbaux, David-Alexandre Tregouet, Viviane Nicaud, et al.
The Journal of Biological Chemistry|February 25, 2003
Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesityDaniel Bach, Sara Pich, Francesc X Soriano, et al.
Journal of Hypertension|March 2, 2006
Sodium excretion as a modulator of genetic associations with cardiovascular phenotypes in the European Project on Genes in HypertensionTatiana Kuznetsova, Jan A Staessen, Eva Brand, et al.
Atherosclerosis|March 14, 2009
Osteopontin gene variation and cardio/cerebrovascular disease phenotypesKlaus Schmidt-Petersen, Eva Brand, Ralph Telgmann, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 30, 2017
Fabry disease under enzyme replacement therapy-new insights in efficacy of different dosagesJohannes Krämer, Malte Lenders, Sima Canaan-Kühl, et al.
Journal of Hypertension|January 15, 2008
SAH gene variants revisited in the European Project On Genes in HypertensionValérie Tikhonoff, Jan A Staessen, Tatiana Kuznetsova, et al.
Circulation. Cardiovascular Genetics|September 12, 2014
Identification of genetic markers for treatment success in heart failure patients: insight from cardiac resynchronization therapyBoris Schmitz, Renata De Maria, Dimitris Gatsios, et al.
Circulation|October 20, 2004
Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretionTatiana Kuznetsova, Jan A Staessen, Lutgarde Thijs, et al.
Journal of the American Society of Nephrology : JASN|February 22, 2014
Patients with Fabry disease after enzyme replacement therapy dose reduction versus treatment switchFrank Weidemann, Johannes Krämer, Thomas Duning, et al.
Orphanet Journal of Rare Diseases|July 1, 2016
Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry diseaseMalte Lenders, Julia B Hennermann, Christine Kurschat, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 20, 2007
Polymorphisms in 33 inflammatory genes and risk of myocardial infarction--a system genetics approachSandrine Barbaux, David-Alexandre Tregouet, Viviane Nicaud, et al.
The Journal of Biological Chemistry|February 25, 2003
Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesityDaniel Bach, Sara Pich, Francesc X Soriano, et al.
Journal of Hypertension|March 2, 2006
Sodium excretion as a modulator of genetic associations with cardiovascular phenotypes in the European Project on Genes in HypertensionTatiana Kuznetsova, Jan A Staessen, Eva Brand, et al.
Atherosclerosis|March 14, 2009
Osteopontin gene variation and cardio/cerebrovascular disease phenotypesKlaus Schmidt-Petersen, Eva Brand, Ralph Telgmann, et al.
Pageof 11